Another Major Drug Approval for Regeneron
Congratulations to BCW member Regeneron on the approval of an important new drug to help patients with rheumatoid arthritis. The U.S. Food and Drug Administration has approved the human antibody drug sarilumab, developed by Regeneron Pharmaceuticals Inc. in Westchester and its French pharmaceutical partner Sanofi and trademarked as Kevzara, to treat adult patients with moderately to severely active rheumatoid arthritis.
The FDA approval came less than two months after the federal agency approved Regeneron’s and Sanofi’s human antibody dupilumab, marketed as Dupixent, as the first biologic medicine used to treat the debilitating itching and widespread rashes afflicting adults with moderate to severe cases of atopic dermatitis.
Similar News Items
BCW member Soulful Synergy announced that they had received new state funding aimed at expanding job training opportunities in the region. Soulful Synergy, led by co-founders Alejandro Alvarez and Dwayne Norris, both BCW Rising Star Alumni, will use the funding to further its mission of preparing residents for careers in construction, clean energy, and other […]
The Westchester Innovation Network (WIN), an initiative of the Business Council of Westchester (BCW), has successfully facilitated a cutting-edge collaboration between technology startup Astrabeam and Tompkins Excavating. The pairing brought advanced sensor fusion technology directly to the field to enhance safety in the construction sector. Astrabeam recently visited the Tompkins Excavating facility to conduct a […]
The Business Council of Westchester (BCW) recently added its voice to a powerful statewide coalition of 30 trade, business, and research organizations, urging New York’s leadership to reject tax increases in the Fiscal Year 2027 budget negotiations. In a formal letter addressed to Gov. Kathy Hochul, Senate Majority Leader Andrea Stewart-Cousins, and Assembly Speaker Carl […]
Become A Member
Join the county’s largest and most influential business organization today.
JOIN NOW!
Leave a Comment
You must be logged in to post a comment.